Pfizer

Pfizer Launches Global Centers of Excellence Network for Vaccine Research
BioSpace
Mon, 01/27/20 - 10:49 pm
Pfizer
vaccines
drug development
Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US
Pharmaforum
Fri, 01/24/20 - 10:11 am
Pfizer
Roche
biosimilars
Avastin
Zirabev
Herceptin
Trazimera
Rituxan
Ruxience
Pfizer to Market Viagra Through Roman's Telehealth Service
Motley Fool
Thu, 01/23/20 - 12:16 pm
Pfizer
Roman
Ro
generics
Viagra
erectile dysfunction
telehealth
digital health
Greenstone
GlaxoSmithKline halts Excedrin production over manufacturing stumble
Fierce Pharma
Tue, 01/21/20 - 11:35 am
GSK
consumer health
Pfizer
Excederin
drug manufacturing
Pfizer teams up with Insilico to mine data for drug targets
Fierce Biotech
Thu, 01/16/20 - 10:09 am
Pfizer
R&D
Insilico
real world evidence
RWE
GSK, Pfizer contradict on the future of consumer health JV — report
Endpoints
Thu, 01/16/20 - 10:03 am
GSK
Pfizer
consumer health
JPMHC 2020
Biogen makes another Alzheimer's bet, paying Pfizer $75M for early-phase drug
Fierce Biotech
Mon, 01/13/20 - 10:51 am
Biogen
Alzheimer's disease
Pfizer
PF-05251749
Upcoming events – Pfizer's abrocitinib and Myovant's relugolix
EP Vantage
Sat, 01/11/20 - 12:01 am
Pfizer
abrocitinib
Dupixent
Sanofi
Myovant
Relugolix
uterine fibroids
Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst
Fierce Pharma
Thu, 01/9/20 - 11:53 pm
Pfizer
Upjohn
Mylan
spinoffs
generics
Pfizer and eFFECTOR Ink $507 Million Cancer Deal
BioSpace
Thu, 01/9/20 - 04:09 pm
Pfizer
Effector
small molecule drugs
cancer
drug development
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
M&A
AbbVie
Allergan
Astellas
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
Merck KGaA, Pfizer's Bavencio set to seal bladder cancer approval after confirmatory trial scores
Endpoints
Mon, 01/6/20 - 10:16 am
Merck KGaA
Pfizer
Bavencio
bladder cancer
FDA
Upcoming events – Karyopharm's myeloma expansion and Pfizer's biz dev news
EP Vantage
Sun, 01/5/20 - 07:11 pm
Karyopharm
Xpovio
Multiple Myeloma
Pfizer
Akcea
Ionis Pharmaceuticals
AKCEA-ANGPTL3-Lrx
Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China
Fierce Pharma
Sun, 01/5/20 - 07:07 pm
Pfizer
Merck
Prevnar 13
Gardasil
vaccines
China
Walvax
Corporate and regulatory developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:39 pm
Astellas
M&A
Qiagen
AstraZeneca
Bausch Health
BeiGene
Celyad
Immunomedics
Merck
Merck KGaA
Ono Pharmaceutical
Pfizer
Pharming
Xyphos Biosciences
Pfizer, BMS, Gilead, AbbVie and others hike prices on hundreds of meds to ring in 2020
Fierce Pharma
Thu, 01/2/20 - 10:46 am
drug pricing
Pfizer
Bristol-Myers Squibb
AbbVie
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
Endpoints
Thu, 12/26/19 - 01:18 pm
Pfizer
Bristol-Myers Squibb
FDA
generics
bloodthinners
Eliquis
Micro Labs
Mylan
Pfizer Strikes JAK Inhibitor Deal Worth Up to $250 Million With Theravance
BioSpace
Mon, 12/23/19 - 11:52 pm
Pfizer
Theravance
JAK inhibitors
Pharma's gene and cell therapy ambitions will kick into high gear in 2020—despite some major hurdles
Fierce Pharma
Thu, 12/19/19 - 01:11 pm
gene therapy
reimbursement
drug manufacturing
Bristol-Myers Squibb
Pfizer
Biomarin
Sarepta Therapeutics
Gilead Sciences
CAR-T
Exact Sciences Should Benefit from Pfizer’s News Today
Motley Fool
Thu, 12/19/19 - 12:05 am
Pfizer
colorectal cancer
EXACT Sciences
FDA
Braftovi
Cologuard

Pages